What Qwince does

Qwince is an Italian healthcare technology company headquartered in Palermo (operating as QWINCE Innovation S.r.l., formerly Securproject.it) that has been active since 2013, building an integrated platform for patient care management, telemedicine, and Real World Evidence generation. Its product portfolio is anchored by adam.os, a modular, interoperable operating system that orchestrates clinical pathways and unifies heterogeneous healthcare data sources using HL7/FHIR standards. Specialized products sit on top of this core: ConCura (chronic and acute patient management with teleconsultation, therapy reminders, and IoMT integration), Teleconsulto (secure video consultations), Puntofarma (qualified medical device infrastructure for care pathway orchestration), Mercurio (mass personalized messaging across PEC/SMS/WhatsApp/Telegram), and research-stage initiatives including the 3D Motion Tracker (wearable mobility assessment) and OBIND (oncology data integration and rational drug design).

The company targets four primary customer segments: pharmaceutical companies (for Real World Evidence and therapy value demonstration), pharmacies and distributors (operational and engagement tools), healthcare operators and facilities (remote monitoring, clinical decision support), and research institutions (biomedical data integration and AI-driven research). Revenue is generated through software platform subscriptions (Mercurio is publicly priced at €125/€290/€500 per month for Bronze/Silver/Gold tiers), professional services for Real World Evidence, and a ConCura Service Center offering patient triage and journey management. Go-to-market combines direct enterprise sales in Italy with channel partnerships through Promofarma, Federfarma, and Assofarm for the pharmacy ecosystem, alongside community-credibility building through EU-funded research projects (OBIND, ConCura AD-EWS under PNRR, xShare under Horizon Europe).

Qwince holds ISO 13485 medical device quality certification, is a member of the NVIDIA Inception Program, and operates with a small team of 1-10 employees. Named customers and partners include MSD (pharma), ASL Pescara and La Maddalena (healthcare providers), Brunel University London, Fondazione Ri.MED and IRIB-CNR (research), and CVBF (regulatory/clinical trials). Strategic technology partners include AiCure (AI behavioral analytics), BioBeat (IoMT wearables), Exprivia and the Università degli Studi di Palermo (oncology research consortium). The company is privately held with no disclosed equity funding rounds and reports no revenue figures; the bulk of recent activity has been financed via non-dilutive public grants.

Name

Qwince

Legal name

QWINCE Innovation S.R.L.

Website

https://qwince.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

Qwince is an Italian healthcare technology company (headquartered in Palermo) that builds the adam.os interoperable platform plus ConCura, Puntofarma, Teleconsulto, and Mercurio products to deliver patient care management, AI clinical decision support, telemedicine, and Real World Evidence services to pharmaceutical companies, pharmacies, hospitals, and research institutions across Italy and the EU.

Ownership category

akta.pro rank

Product category

Healthcare Technology Platforms

NAICS

Software Publishers (5132), Software Publishers (51321), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)

akta.pro primary industry

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

akta.pro secondary industries

Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO), Virtual Care Team Collaboration & Provider-to-Provider Teleconsult Platforms (eConsults) (HLALABAI), Revenue Cycle, Coding & Telehealth Compliance Platforms (for provider orgs) (HLALABAM), Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored) (HLALACAK)

Keywords

• Healthcare technology platforms
• Clinical decision support
• Remote patient monitoring
• Real world evidence
• Telemedicine solutions

Headquarters

HQ city

Milano

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Software Platform Subscriptions: Qwince generates recurring revenue through subscriptions to its platforms including ConCura, Puntofarma, Teleconsulto, and adam.os, which are offered to healthcare organizations, pharmaceutical companies, and pharmacy networks.
2. Mercurio Messaging Platform: Mercurio operates on a tiered subscription model (Bronze, Silver, Gold) with different message volume limits and storage capacities, providing mass personalized messaging services for healthcare compliance communication.
3. Real World Evidence Services: Qwince provides data analysis and Real World Evidence generation services to pharmaceutical partners, transforming real-world data into strategic evidence to demonstrate therapy value.
4. Professional Healthcare Services: The ConCura platform includes a dedicated Service Center providing pro-active organizational triage and patient guidance services for healthcare journey management.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Qwince sells a modular healthcare technology ecosystem anchored by adam.os, a software operating system that integrates clinical pathways, unifies information flows, and enables AI capabilities across heterogeneous health data sources. Built on this core platform, the company offers ConCura for patient care management and teleconsultation (a qualified medical device), Teleconsulto for secure video consultations, Puntofarma for clinical coordination across clinics, hospitals, and pharmacies, and Mercurio for multi-channel healthcare-compliant mass messaging. The company also delivers professional services for Real World Evidence generation to pharmaceutical and research partners.

Product overview

Qwince operates as a platform-plus-modules architecture offering healthcare technology solutions. The ecosystem is anchored by adam.os, a modular healthcare operating system that orchestrates data integration and AI capabilities. This core platform connects multiple specialized products: ConCura (patient management and teleconsultation platform), Teleconsulto (secure video consultation), Puntofarma (clinical coordination infrastructure), and Mercurio (communication engine). Research initiatives include the 3D Motion Tracker for mobility assessment and Obind for oncology data analysis. The company targets pharmaceutical companies, distributors, pharmacies, healthcare operators and facilities, and research institutions to transform Real World Data into strategic evidence for evidence-based medicine.

Differentiator

Problem solved

Functional benefit

Brands

• adam.os: Healthcare operating system that integrates existing systems, unifies information flows, and enables advanced AI functions. Acts as a central 'brain' orchestrating the entire clinical pathway for healthcare operators and patient care.
• ConCura
• Teleconsulto
• Puntofarma
• Mercurio
• Neuralya

Products and services

• adam.os adam.os is a modular, interoperable software operating system for healthcare that acts as a central brain, integrating existing systems, unifying information flows, and enabling advanced AI functions. It orchestrates the entire clinical pathway for healthcare operators and patient care journeys, processing data in aggregated and anonymized form across heterogeneous sources.
• ConCura ConCura is a software medical device platform for patient management and follow-up in chronic disease and acute event care. It supports appointment booking, therapy reminders, teleconsultation, and integrates with IoMT devices (e.g., BioBeat Chest Monitor) for remote monitoring of vital signs, with a dedicated human Service Center providing pro-active triage and patient guidance.
• Teleconsulto Teleconsulto is a secure teleconsultation platform enabling real-time video consultations between patients and healthcare providers. It integrates with adam.os to provide clinicians with comprehensive, real-time patient data from connected devices and services during consultations.
• Puntofarma Puntofarma is a qualified medical device technological infrastructure enabling clinics, hospitals, research centers, and pharmaceutical companies to securely orchestrate patient care pathways. It serves as a digital engine for complex chronic disease management, addressing process fragmentation and low therapeutic adherence.
• Mercurio Mercurio is an advanced mass messaging technology for sending personalized messages to large recipient groups via PEC, SMS, WhatsApp, and Telegram with complete traceability and receipt reconciliation. It is a healthcare-compliant communication engine natively integrated within the adam.os ecosystem, offered on tiered subscriptions (Bronze €125/month up to 40k sends, Silver €290/month up to 200k sends, Gold €500/month up to 2M sends).
• Real World Evidence Generation Services Professional services that transform real-world healthcare data into strategic Real World Evidence, predictive reports, and recommendations for pharmaceutical and research partners. Includes data analysis, patient engagement insights, therapy adherence modeling, and therapy value demonstration support.

Quantifiable outcome

• 80% of chronic patients consider digital health platforms necessary for managing their pathology (Qwince-Doxa Pharma survey, July 2023)
• +2 more outcomes

Named customers9 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature10 records

Partnerships

17 partnerships are on record, tiered core, major and minor.

• NVIDIAcoreTechnology or IntegrationQwince is a member of the NVIDIA Inception Program, gaining access to NVIDIA's AI, computing, and GPU technologies including RTX GPUs and BioNeMo platform for developing healthcare AI solutions such as telehealth and patient data analysis.
• AiCurecoreStrategic or Co-development PartnerStrategic partnership to bring AiCure's AI-based predictive technology for drug development and chronic patient care to the Italian market. Qwince shares AiCure's holistic patient view for improved engagement and behavioral data quality.
• CVBF (Consorzio per Valutazioni Biologiche e Farmacologiche)coreStrategic or Co-development PartnerCollaboration on xShare project (Horizon Europe) to demonstrate how ConCura can apply European Health Data Space (EHDS) standards for secondary health data research, enabling secure identification of patients eligible for clinical trials.
• Brunel University LondoncoreStrategic or Co-development PartnerResearch collaboration on Major Project DM3306 to develop user experience and gesture input for THALMIC LABS MYO technology for elderly and disabled persons with low mobility. Qwince developed a mobile app prototype for activity level assessment.
• La Maddalena S.p.A. – Dipartimento Oncologico di 3° LivellocoreStrategic or Co-development PartnerClinical research partner for ConCura AD-EWS project, focusing on cardiotoxicity monitoring in oncology patients during and after chemotherapy treatment using BioBeat Chest Monitor devices.
• Clinica Ruesch di Napoli (Gruppo GVM)coreStrategic or Co-development PartnerClinical partner for ConCura ADSF project, implementing AI-based decision support to predict deterioration in frailty levels among chronic and elderly patients managed at home, using BioBeat Chest Monitor devices.
• Exprivia S.p.A.majorStrategic or Co-development PartnerLead partner in the OBIND project, working with Qwince Innovation to develop an expert system integrating medicinal chemistry and transcriptomics/proteomics data for rational drug design in oncology.
• Università degli Studi di Palermo (UNIPA)majorStrategic or Co-development PartnerResearch partner in OBIND project through multiple departments: Dipartimento di Ingegneria dell'Innovazione Industriale e Digitale (DIID), Dipartimento di Scienze Economiche Aziendali e Statistiche (DSEAS), Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), and Centro ATeN.
• Fondazione Ri.MEDmajorStrategic or Co-development PartnerResearch partner in OBIND oncological research project, contributing to the development of systems for aggregating and analyzing heterogeneous cancer research datasets.
• OS2 S.R.L.minorStrategic or Co-development PartnerProject partner in OBIND oncological research initiative.
• 2038 Innovation CompanyminorStrategic or Co-development PartnerProject partner in OBIND oncological research initiative.
• IRIB-CNR (Istituto Per La Ricerca e l'Innovazione Biomedica)majorStrategic or Co-development PartnerResearch partner in OBIND project, contributing expertise in biomedicine and molecular immunology for oncological data integration research.
• BioBeatcoreTechnology or IntegrationProvider of innovative 'Chest Monitor' devices for vital sign detection and remote patient monitoring, used in ConCura AD-EWS and ADSF projects for real-time health data collection.
• BVA Doxa PharmaminorStrategic or Co-development PartnerResearch collaboration for patient chronic disease survey on digital health adoption, published July 2023, providing market insights into patient attitudes toward healthcare technology.
• Promofarma / FederfarmacoreChannel Partner/ Reseller/ DistributorE-commerce platform partnership (marketplace.promofarma.it) offering innovative technological solutions for Federfarma-associated pharmacies in Italy, including digital invoicing, medical devices, and patient adherence tools.
• DAFNE ConsortiumminorStrategic or Co-development PartnerCollaboration on pharmaceutical document digitization project, working with PromoFarma, Federfarma, and Assofarm to implement full digitization of delivery documents, digital archiving, and electronic invoice matching.
• AssofarmminorChannel Partner/ Reseller/ DistributorCollaboration on pharmaceutical document digitization solutions alongside DAFNE Consortium, PromoFarma, and Federfarma for Italian pharmacy network digital transformation.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Doctolib: Leading European telehealth and practice-management platform operating in Italy and France, offering online booking, teleconsultation, and patient management — comparable to Qwince's ConCura and Teleconsulto modules but at much larger scale and broader scope.
• Teladoc Health: Global telehealth and virtual care platform offering chronic condition management, RPM, and provider-to-provider consultations — a broad incumbent illustrating the scale Qwince's Teleconsulto and ConCura compete against.
• Docplanner / MioDottore: Online healthcare booking and practice management platform with a major presence in Italy via MioDottore, including telemedicine features — overlaps with Qwince's Teleconsulto and Puntofarma offerings in the Italian provider ecosystem.

Direct peers

• AiCure: US-based AI patient monitoring and adherence platform for clinical trials and chronic care — already a strategic partner of Qwince and directly comparable in AI behavioral analytics and patient adherence prediction.
• Doccla: UK virtual ward and remote patient monitoring provider serving hospitals with continuous vital sign monitoring — comparable to Qwince's BioBeat-integrated ConCura AD-EWS/ADSF modules for chronic and elderly patients.
• Luscii: Dutch remote patient monitoring and virtual care platform used across European hospitals for chronic disease and post-discharge monitoring — closely comparable to ConCura's chronic care and teleconsultation capabilities.
• Huma (formerly Medopad): UK-based digital health platform combining RPM, patient engagement, and AI-driven predictive analytics for hospitals and pharma — directly comparable to Qwince's adam.os + ConCura + AD-EWS stack.

Regional players

• Exprivia: Italian IT services and healthcare technology vendor, partner of Qwince in OBIND — comparable as a domestic health-IT player providing software platforms and clinical decision support to Italian healthcare organizations.
• Medgate: Swiss telemedicine and digital health platform offering 24/7 teleconsultations and chronic care programs — a European regional peer comparable in teleconsultation and chronic disease management scope.
• Healthware Group: Italian digital health consultancy and technology company serving pharma and providers with digital therapeutics and engagement solutions — comparable to Qwince's pharmaceutical RWE and patient engagement focus in the Italian market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/qwinceit
• LinkedInlinkedin.com/company/qwince
• Xx.com/qwinceit

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qwince